WOLVERINE TRADING, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$26,826
-28.3%
10,200
-7.3%
0.00%
Q2 2023$37,400
+100981.1%
11,000
-15.0%
0.00%
Q1 2023$37
-99.9%
12,944
+8.8%
0.00%
Q1 2022$34,000
-10.5%
11,900
+0.4%
0.00%
Q4 2021$38,000
-55.3%
11,847
-2.1%
0.00%
Q3 2021$85,000
-30.9%
12,100
-11.7%
0.00%
Q2 2021$123,000
-65.9%
13,700
-60.5%
0.00%
Q4 2020$361,000
-31.0%
34,710
-33.3%
0.00%
-100.0%
Q3 2020$523,000
+29.1%
52,059
+31.5%
0.00%0.0%
Q2 2020$405,000
-23.1%
39,600
-36.7%
0.00%0.0%
Q1 2020$527,000
-44.1%
62,608
-44.1%
0.00%
-50.0%
Q4 2019$942,000
-3.4%
112,076
+28.4%
0.00%
-33.3%
Q3 2019$975,000
+25.2%
87,258
+42.5%
0.00%
+50.0%
Q2 2019$779,000
-72.8%
61,216
-17.0%
0.00%
-75.0%
Q1 2019$2,861,000
+140.8%
73,772
+30.9%
0.01%
+100.0%
Q4 2018$1,188,000
-31.4%
56,347
+49.1%
0.00%
+33.3%
Q3 2018$1,733,000
-14.0%
37,796
+27.6%
0.00%
-40.0%
Q2 2018$2,015,0000.0%29,6240.0%0.01%0.0%
Q1 2018$2,015,000
+30.4%
29,624
+89.7%
0.01%
-16.7%
Q4 2017$1,545,000
-38.2%
15,619
-25.2%
0.01%
-33.3%
Q3 2017$2,500,000
-59.8%
20,876
-70.8%
0.01%
-67.9%
Q2 2017$6,212,000
+584.9%
71,599
+195.9%
0.03%
+460.0%
Q1 2017$907,00024,2000.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders